How Mark Cuban’s drug company compares with PBMs on price: 7 notes
A September analysis by consulting firm 3 Axis Advisors, completed on behalf of Mark Cuban Cost Plus Drug Co., compared the company’s prices with what pharmacy benefit managers charged 13 commercial employer plans for the same drugs in 2024. Here are seven things to know: The post How Mark Cuban’s drug company compares with PBMs on price: 7 notes appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.